BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12205360)

  • 1. Successful treatment with primary angioplasty of acute myocardial infarction during cerebellar hemorrhage.
    Paolillo V; Gastaldo D; Ferrero B; Sega P; Oliveri G
    J Invasive Cardiol; 2002 Sep; 14(9):562-4. PubMed ID: 12205360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary coronary intervention in acute myocardial infarction.
    Kim CX; Davidson CJ
    Ital Heart J; 2004 Jun; 5 Suppl 6():76S-82S. PubMed ID: 15185919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
    Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
    Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
    J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel technique for coronary bifurcation lesions: cutting balloons, drug-eluting stents and the kissing technique.
    Wong CB; Hardin S
    J Invasive Cardiol; 2005 Feb; 17(2):108-10. PubMed ID: 15687538
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions.
    Petronio AS; De Carlo M; Rossini R; Amoroso G; Limbruno U; Ciabatti N; Palagi C; Caravelli P; Mariani M
    Ital Heart J; 2004 Feb; 5(2):114-9. PubMed ID: 15086140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
    Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
    Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary angioplasty for acute myocardial infarction.
    Gordon PC
    Med Health R I; 2001 Feb; 84(2):44-50. PubMed ID: 11272659
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of glycoprotein IIb/IIIa inhibitor use during primary coronary angioplasty: results of propensity analysis using the New York State Percutaneous Coronary Intervention Reporting System.
    Srinivas VS; Skeif B; Negassa A; Bang JY; Shaqra H; Monrad ES
    Am J Cardiol; 2007 Feb; 99(4):482-5. PubMed ID: 17293189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcome after paclitaxel-eluting stents in patients with acute and subacute myocardial infarction. A clinical study.
    Margheri M; Giglioli C; Comeglio M; Valente S; Chechi T; Falai M; Becherini R; Vittori G; Parigi E; Lazzeri C; Gensini GF
    Ital Heart J; 2004 Jul; 5(7):536-40. PubMed ID: 15487272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)].
    Oltrona L; Mafrici A; Marzegalli M; Fiorentini C; Pirola R; Vincenti A;
    Ital Heart J Suppl; 2005 Aug; 6(8):489-97. PubMed ID: 16161503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transradial primary angioplasty and stenting in Indian patients with acute myocardial infarction: acute results and 6-month follow-up.
    Ranjan A; Patel TM; Shah SC; Malhotra H; Patel R; Vayada N; Pothiwala R; Fonseca K; Tanwar NS
    Indian Heart J; 2005; 57(6):681-7. PubMed ID: 16521638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction.
    Steen H; Lehrke S; Wiegand UK; Merten C; Schuster L; Richardt G; Kulke C; Gehl HB; Lima JA; Katus HA; Giannitsis E
    Am Heart J; 2005 Mar; 149(3):564. PubMed ID: 15864217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
    Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
    Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.